IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Evonik Hones Pharma Focus with Sale of U.K. Unit

12:54 PM MST | December 12, 2008 | Alex Scott

Evonik says the recent sale of its Seal Sands, U.K. fine chemical facility and the planned introduction in the next few weeks of a pharmaceutical ingredient facility at Nanning, China will “significantly” increase its active pharma ingredient (API) production capacity while reducing its exposure to potentially lower-value non-GMP material production. Also, the Seal Sands divestment was made without the Evonik group losing any chemistries, Rudolf Hanko, head of Evonik’s Exclusive Synthesis & Amino Acids business line, tells CW. Evonik...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa